ONC-206

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NameONC-206
Drug Alias NameONC-206JZP3507JZP-3507
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSolid tumoursDiffuse midline gliomaChoroid Plexus Neoplasms +[21] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsSwitzerland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncoceutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesChimerix IncJazz Pharmaceuticals PlcOhara Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursDiffuse midline gliomaChoroid Plexus Neoplasms +[21] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A